OR WAIT null SECS
MJH Life Sciences
Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.
September 01, 2014
An expert discusses how companies should be preparing to meet the requirements of the Drug Supply Chain Security Act, which requires phase-in of requirements to prevent counterfeiting.
August 20, 2014
Manufacturers can identify and reduce waste using tools such as value-stream mapping.
August 02, 2014
The US federal Drug Quality and Security Act (DQSA) and more specifically the Drug Supply Chain Security Act (DSCSA), referring to Title II of the law, requires phase-in of requirements to prevent counterfeiting. An expert discusses how companies should be preparing to meet the requirements of the DSCSA.
July 16, 2014
Pharmaceutical Technology’s survey collected industry feedback on trends and the utility of equipment used in finished drug-product manufacturing.
July 02, 2014
PharmTech's annual equipment and manufacturing survey shows gains in process analytical technology and indicates areas for future innovation.
Nitrogen dioxide can sterilize and depyrogenate an aseptic fill area in a blow-fill-seal process.